CMPD1 inhibited human gastric cancer cell proliferation by inducing apoptosis and G2/M cell cycle arrest

[1]  F. Cui,et al.  C‐Myc regulates radiation‐induced G2/M cell cycle arrest and cell death in human cervical cancer cells , 2017, The journal of obstetrics and gynaecology research.

[2]  Qiao Chen,et al.  Therapeutic potential of ADAM17 modulation in gastric cancer through regulation of the EGFR and TNF-α signalling pathways , 2017, Molecular and Cellular Biochemistry.

[3]  Byung-Hyun Park,et al.  Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases , 2016, Oncotarget.

[4]  B. Nagari,et al.  Positive Peritoneal Lavage Cytology –Implications for Staging and Management of Gastric Cancer , 2016, Indian Journal of Surgical Oncology.

[5]  M. Gaestel,et al.  Extracellular-signal regulated kinase (Erk1/2), mitogen-activated protein kinase-activated protein kinase 2 (MK2) and tristetraprolin (TTP) comprehensively regulate injury-induced immediate early gene (IEG) response in in vitro liver organ culture. , 2016, Cellular signalling.

[6]  J. Visvader,et al.  Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer , 2016, Oncogene.

[7]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[8]  T. Hofmann,et al.  The DNA damage-induced cell death response: a roadmap to kill cancer cells , 2016, Cellular and Molecular Life Sciences.

[9]  M. Chircop,et al.  Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2 , 2015, Cell Death Discovery.

[10]  A. Trumpp,et al.  A Synergistic Interaction between Chk1- and MK2 Inhibitors in KRAS-Mutant Cancer , 2015, Cell.

[11]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[12]  Karl A. Merrick,et al.  A Pleiotropic RNA-Binding Protein Controls Distinct Cell Cycle Checkpoints to Drive Resistance of p53-Defective Tumors to Chemotherapy. , 2014, Cancer cell.

[13]  A. Pliss,et al.  Transformations of the macromolecular landscape at mitochondria during DNA-damage-induced apoptotic cell death , 2014, Cell Death and Disease.

[14]  Yi Tang,et al.  Synergistic effect of arginine-specific ADP-ribosyltransferase 1 and poly(ADP-ribose) polymerase-1 on apoptosis induced by cisplatin in CT26 cells. , 2014, Oncology reports.

[15]  M. Karbowski,et al.  Drp1 is dispensable for apoptotic cytochrome c release in primed MCF10A and fibroblast cells but affects Bcl‐2 antagonist‐induced respiratory changes , 2014, British journal of pharmacology.

[16]  M. Yaffe,et al.  Phospho-Ser/Thr-binding domains: navigating the cell cycle and DNA damage response , 2013, Nature Reviews Molecular Cell Biology.

[17]  J. Arthur,et al.  Mitogen-activated protein kinases in innate immunity , 2013, Nature Reviews Immunology.

[18]  Q. Wei,et al.  Cleavage of poly (ADP-ribose) polymerase-1 is involved in the process of porcine ovarian follicular atresia. , 2013, Animal reproduction science.

[19]  R. Perona,et al.  Targeting Chk2 improves gastric cancer chemotherapy by impairing DNA damage repair , 2013, Apoptosis.

[20]  A. Nebreda,et al.  SnapShot: p38 MAPK Substrates , 2013, Cell.

[21]  R. Burbano,et al.  Epigenetic mechanisms in gastric cancer. , 2012, Epigenomics.

[22]  E. Holland,et al.  DNA damage response and growth factor signaling pathways in gliomagenesis and therapeutic resistance. , 2011, Cancer research.

[23]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[24]  David R. Anderson,et al.  A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation , 2010, Journal of Pharmacology and Experimental Therapeutics.

[25]  M. Gaestel,et al.  p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication , 2010, Proceedings of the National Academy of Sciences.

[26]  M. Yaffe,et al.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2. , 2009, Current opinion in cell biology.

[27]  Mark J. Smyth,et al.  The TRAIL apoptotic pathway in cancer onset, progression and therapy , 2008, Nature Reviews Cancer.

[28]  C. Britten,et al.  G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer , 2008, British Journal of Cancer.

[29]  B. Xiao,et al.  Suppression of C-myc Expression Associates with Anti-Proliferation of Aloe-Emodin on Gastric Cancer Cells , 2008, Cancer investigation.

[30]  Michael B Yaffe,et al.  p53-deficient cells rely on ATM- and ATR-mediated checkpoint signaling through the p38MAPK/MK2 pathway for survival after DNA damage. , 2007, Cancer cell.

[31]  Michael B Yaffe,et al.  MAPKAP kinase-2 is a cell cycle checkpoint kinase that regulates the G2/M transition and S phase progression in response to UV irradiation. , 2005, Molecular cell.

[32]  C. Pargellis,et al.  Discovery and characterization of a substrate selective p38alpha inhibitor. , 2004, Biochemistry.

[33]  M. Jordan,et al.  Microtubules as a target for anticancer drugs , 2004, Nature Reviews Cancer.

[34]  R. Dickson,et al.  c-Myc alters the DNA damage-induced G2/M arrest in human mammary epithelial cells , 2003, British Journal of Cancer.

[35]  G. Zachos,et al.  Chk1‐deficient tumour cells are viable but exhibit multiple checkpoint and survival defects , 2003, The EMBO journal.

[36]  D. Aggarwal,et al.  Paclitaxel and its formulations. , 2002, International journal of pharmaceutics.

[37]  N. Mailand,et al.  The ATM–Chk2–Cdc25A checkpoint pathway guards against radioresistant DNA synthesis , 2001, Nature.

[38]  K. Bhalla,et al.  The role of Apaf-1, caspase-9, and bid proteins in etoposide- or paclitaxel-induced mitochondrial events during apoptosis. , 2000, Cancer research.

[39]  G. Evan,et al.  Metabolism of c‐myc gene products: c‐myc mRNA and protein expression in the cell cycle. , 1985, EMBO Journal.

[40]  P. Kassab,et al.  lnterleukin-8 gene polymorphism and susceptibility to gastric cancer in a Brazilian population. , 2012, Biological research.

[41]  W. Tiyaboonchai,et al.  Effects of silk sericin on the proliferation and apoptosis of colon cancer cells. , 2012, Biological research.

[42]  S. Gross,et al.  Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells , 2009, Leukemia.

[43]  M. Bajpai,et al.  MK2: a novel molecular target for anti-inflammatory therapy. , 2008, Expert opinion on therapeutic targets.

[44]  J. Haveman,et al.  Clonogenic assay of cells in vitro , 2006, Nature Protocols.

[45]  H. Espejo,et al.  [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.